dont see any reason why they would have to tell us. Not a p2 test. More like a I would hope any partner is running tests so they can pay up big for a partnership.
Just guessing, but maybe in Greece, Germany, Israel, Aust. or one of the other countries they have operated in, may have different rules for testing drugs? I have long thought that this is likely and the implications, if correct, are large.....
I fear everyone are over interpreting the example 'embodiments' in the seizure control patent description section. These are not claims, but examples of the kind embodiments that someone skilled in the art would conceive as a possible uses of the invention. It is about disclosing as much as possible to prevent others from navigating and protecting some use of the invention that you'd rather not see happening. Once disclosed, whether ultimately useful or not, no one can patent that method of use.